| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.1 |
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | 0.45 | 0.1 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.071 | 0.1 |
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | -0.048 | 0.1 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | -0.048 | 0.1 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.06 | 0.1 |